Targeting TLR4 during vaccination boosts MAdCAM-1


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
06 05 2022
Historique:
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 11 5 2022
Statut: ppublish

Résumé

The failure to generate enduring humoral immunity after vaccination is a hallmark of advancing age. This can be attributed to a reduction in the germinal center (GC) response, which generates long-lived antibody-secreting cells that protect against (re)infection. Despite intensive investigation, the primary cellular defect underlying impaired GCs in aging has not been identified. Here, we used heterochronic parabiosis to demonstrate that GC formation was dictated by the age of the lymph node (LN) microenvironment rather than the age of the immune cells. Lymphoid stromal cells are a key determinant of the LN microenvironment and are also an essential component underpinning GC structure and function. Using mouse models, we demonstrated that mucosal adressin cell adhesion molecule-1 (MAdCAM-1)-expressing lymphoid stromal cells were among the first cells to respond to NP-KLH + Alum immunization, proliferating and up-regulating cell surface proteins such as podoplanin and cell adhesion molecules. This response was essentially abrogated in aged mice. By targeting TLR4 using adjuvants, we improved the MAdCAM-1

Identifiants

pubmed: 35522725
doi: 10.1126/sciimmunol.abk0018
pmc: PMC7612953
mid: EMS145908
doi:

Substances chimiques

Cell Adhesion Molecules 0
TLR4 protein, human 0
Tlr4 protein, mouse 0
Toll-Like Receptor 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabk0018

Subventions

Organisme : Medical Research Council
ID : MC_U105178805
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0407
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V009591/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0408
Pays : United Kingdom
Organisme : European Research Council
ID : 637801
Pays : International
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N011740/1
Pays : United Kingdom

Références

J Exp Med. 2014 Jun 2;211(6):1109-22
pubmed: 24863064
Sci Immunol. 2018 Aug 10;3(26):
pubmed: 30097537
Vaccine. 2009 May 18;27(23):3063-71
pubmed: 19428920
J Immunol. 2007 Oct 1;179(7):4444-50
pubmed: 17878340
JAMA. 1994 Dec 7;272(21):1661-5
pubmed: 7966893
Immunity. 2013 Nov 14;39(5):912-24
pubmed: 24184055
Immunity. 2015 Dec 15;43(6):1186-98
pubmed: 26682988
J Immunol. 2016 Dec 1;197(11):4351-4359
pubmed: 27794001
Front Immunol. 2018 Feb 19;9:295
pubmed: 29515589
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12139-44
pubmed: 25092322
J Immunol. 2008 Nov 1;181(9):6189-200
pubmed: 18941209
J Clin Pathol. 1980 May;33(5):454-61
pubmed: 7400343
Vaccine. 2006 Feb 20;24(8):1159-69
pubmed: 16213065
Semin Immunol. 2008 Feb;20(1):14-25
pubmed: 18261920
Nat Immunol. 2015 Jan;16(1):75-84
pubmed: 25347465
Immunity. 2018 May 15;48(5):1014-1028.e6
pubmed: 29752062
J Exp Med. 2004 Dec 20;200(12):1613-22
pubmed: 15611289
Cell Rep. 2017 Jan 10;18(2):406-418
pubmed: 28076785
Nature. 2014 Oct 23;514(7523):498-502
pubmed: 25341788
Cell Rep. 2020 Dec 29;33(13):108567
pubmed: 33378682
Vaccine. 2009 Oct 9;27(43):5956-63
pubmed: 19679214
J Immunol. 2003 Dec 1;171(11):5975-87
pubmed: 14634109
Elife. 2021 Nov 02;10:
pubmed: 34726156
Vaccine. 2016 May 27;34(25):2847-54
pubmed: 27102821
Front Immunol. 2018 Oct 25;9:2469
pubmed: 30410492
PLoS Pathog. 2015 Jul 23;11(7):e1005027
pubmed: 26204259
Biogerontology. 2017 Oct;18(5):723-738
pubmed: 28501894
J Craniomaxillofac Surg. 1993 Jul;21(5):207-9
pubmed: 8360354
NPJ Vaccines. 2018 Sep 4;3:34
pubmed: 30210819
J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1018-1026
pubmed: 28582491
Sci Rep. 2016 Apr 25;6:25051
pubmed: 27109638
J Immunol. 2015 Nov 15;195(10):4781-91
pubmed: 26453751
Eur J Immunol. 2013 Feb;43(2):488-98
pubmed: 23169007
Elife. 2020 Mar 24;9:
pubmed: 32204792
J Exp Med. 2019 Aug 5;216(8):1857-1873
pubmed: 31175140
Aging Cell. 2012 Oct;11(5):732-40
pubmed: 22607653
Semin Immunol. 2018 Dec;40:83-94
pubmed: 30501873
J Gerontol A Biol Sci Med Sci. 2019 Oct 4;74(11):1734-1743
pubmed: 30721932
J Cell Sci. 2021 Jul 15;134(14):
pubmed: 34184727
Immunohorizons. 2018 May;2(5):155-163
pubmed: 30706058
Lymphat Res Biol. 2008;6(2):77-83
pubmed: 18564922
Nature. 2008 Jun 19;453(7198):1122-6
pubmed: 18496530
Sci Rep. 2016 Aug 02;6:30842
pubmed: 27480406
Science. 2001 Nov 30;294(5548):1933-6
pubmed: 11729320
J Immunol. 2002 Nov 1;169(9):4697-701
pubmed: 12391175
Curr Opin Immunol. 2017 Apr;45:103-111
pubmed: 28319729
Front Immunol. 2017 Jun 14;8:706
pubmed: 28659930
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E109-18
pubmed: 24367096
J Exp Med. 2021 Jul 5;218(7):
pubmed: 33988714
Clin Microbiol Infect. 2012 Oct;18 Suppl 5:100-8
pubmed: 22862783
Cell. 2020 Oct 15;183(2):290-295
pubmed: 33064982
Immunology. 2016 May;148(1):92-101
pubmed: 26840375
Ann Anat. 2004 Aug;186(4):337-47
pubmed: 15481841
Immunology. 2017 Jun;151(2):239-247
pubmed: 28207940
Ageing Res Rev. 2004 Jan;3(1):15-29
pubmed: 15163101
J Exp Med. 2011 Nov 21;208(12):2497-510
pubmed: 22042977
Immunol Lett. 2022 Jan;241:1-14
pubmed: 34767859
Nat Immunol. 2020 Jun;21(6):649-659
pubmed: 32424359
Immunity. 2012 Aug 24;37(2):276-89
pubmed: 22884313
J Exp Med. 1996 Mar 1;183(3):959-70
pubmed: 8642299
J Exp Med. 2021 Oct 4;218(10):
pubmed: 34424268
Nat Immunol. 2014 Oct;15(10):973-81
pubmed: 25151489
Front Immunol. 2012 Jul 12;3:200
pubmed: 22807928
J Immunol. 2003 Feb 1;170(3):1267-73
pubmed: 12538685
J Exp Med. 2019 Oct 7;216(10):2242-2252
pubmed: 31324739
Eur J Immunol. 2002 Oct;32(10):2817-26
pubmed: 12355434
PLoS One. 2011 Jan 26;6(1):e16333
pubmed: 21298114
Eur J Immunol. 2010 Mar;40(3):638-42
pubmed: 20201020
Nat Immunol. 2012 Apr 01;13(5):499-510
pubmed: 22466668
Nature. 2005 Feb 17;433(7027):760-4
pubmed: 15716955
Immunity. 2010 Jul 23;33(1):84-95
pubmed: 20643339
Immunity. 2012 Oct 19;37(4):721-34
pubmed: 22940098
J Clin Invest. 2013 Mar;123(3):958-65
pubmed: 23454758
Immunity. 2016 Jan 19;44(1):116-130
pubmed: 26795247

Auteurs

Alice E Denton (AE)

Immunology Programme, Babraham Institute, Cambridge, UK.
Department of Immunology and Inflammation, Imperial College London, London, UK.

James Dooley (J)

Immunology Programme, Babraham Institute, Cambridge, UK.
Adaptive Immunology Laboratory, VIB and University of Leuven, Leuven, Belgium.

Isabella Cinti (I)

Department of Immunology and Inflammation, Imperial College London, London, UK.

Alyssa Silva-Cayetano (A)

Immunology Programme, Babraham Institute, Cambridge, UK.

Sigrid Fra-Bido (S)

Immunology Programme, Babraham Institute, Cambridge, UK.

Silvia Innocentin (S)

Immunology Programme, Babraham Institute, Cambridge, UK.

Danika L Hill (DL)

Immunology Programme, Babraham Institute, Cambridge, UK.
Department of Immunology and Pathology, Central Clinical School, Monash University and Alfred Hospital, Melbourne, Victoria, Australia.

Edward J Carr (EJ)

Immunology Programme, Babraham Institute, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge, UK.
Francis Crick Institute, London, UK.

Andrew N J McKenzie (ANJ)

Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.

Adrian Liston (A)

Immunology Programme, Babraham Institute, Cambridge, UK.
Adaptive Immunology Laboratory, VIB and University of Leuven, Leuven, Belgium.

Michelle A Linterman (MA)

Immunology Programme, Babraham Institute, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH